Nonalcoholic Fatty Liver Disease: A Global Perspective

Area of Science:

• Hepatology
• Metabolic Disorders
• Genetics

Background:

• Nonalcoholic fatty liver disease (NAFLD) prevalence is increasing globally, reaching levels in Asia comparable to Western countries.
• NAFLD is particularly prevalent in patients with diabetes mellitus, a known risk factor for severe liver disease.
• The condition is increasingly recognized in non-obese individuals, termed 'lean NAFLD', particularly in Asia.

Purpose of the Study:

• To highlight the growing global prevalence of NAFLD, emphasizing its significant rise in Asia.
• To underscore the association between NAFLD, diabetes mellitus, and the risk of severe liver disease.
• To discuss the evolving understanding of NAFLD, including genetic predispositions and the utility of the term 'metabolic dysfunction-associated fatty liver disease'.

Main Methods:

• Literature review and synthesis of current epidemiological data on NAFLD prevalence.
• Analysis of the interplay between NAFLD, diabetes mellitus, and genetic factors like PNPLA3 polymorphisms.
• Examination of risk factors and management strategies, including lifestyle interventions for diverse patient populations.

Main Results:

• NAFLD is no longer a "Western disease" and China anticipates the largest increase in cases.
• Patients with diabetes mellitus are a key demographic for NAFLD screening due to higher risk of severe liver disease.
• Polygenic risk scores and recognition of lean NAFLD are emerging areas in understanding disease predisposition.

Conclusions:

• NAFLD is a global health challenge requiring focused clinical and research attention, with a shift towards the term metabolic dysfunction-associated fatty liver disease.
• Early identification and intervention in high-risk groups, such as individuals with diabetes, are crucial.
• Understanding the genetic and metabolic underpinnings of NAFLD is essential for effective management across different ethnic groups and body types.